Cargando…

Editorial: Natural products and brain energy metabolism: Astrocytes in neurodegenerative diseases Volume II

Detalles Bibliográficos
Autores principales:	Wang, Fushun, Xu, Shijun, Pan, Fang, Verkhratsky, Alex, Huang, Jason H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887323/ https://www.ncbi.nlm.nih.gov/pubmed/36733501 http://dx.doi.org/10.3389/fphar.2023.1137554

Ejemplares similares

Editorial: Natural products and brain energy metabolism: Astrocytes in neurodegenerative diseases
por: Wang, Fushun, et al.
Publicado: (2022)

Editorial: Natural products as drivers in drug development for neurodegenerative disorders, volume II
por: Silva, Joana, et al.
Publicado: (2023)

Editorial: Neurotransmitters and Emotions, Volume II
por: Wang, Fushun, et al.
Publicado: (2022)

Editorial: Role of Astrocytes in Seizures Induced by Traumatic Brain Injury
por: Wang, Fushun, et al.
Publicado: (2020)

Brain Energy Metabolism: Astrocytes in Neurodegenerative Diseases
por: Chen, Zhenlei, et al.
Publicado: (2022)

Editorial: Herbal medicines in managing stroke and neurodegenerative diseases—Is there evidence based on basic and clinical studies?, volume II
por: Liang, Huazheng, et al.
Publicado: (2022)

Editorial: Natural products as drivers in drug development for neurodegenerative disorders
por: Silva, Joana, et al.
Publicado: (2022)

Editorial: Bone and Cartilage Diseases – The Role and Potential of Natural Products, Volume II
por: Pei, Ming, et al.
Publicado: (2023)

Editorial: Natural products as an emerging therapeutic alternative for the treatment of anxiety and depression, Volume II
por: Khan, Ajmal, et al.
Publicado: (2022)

Editorial: New trends in natural product research for inflammatory and infectious diseases: Volume II
por: Ribeiro-Filho, Jaime, et al.
Publicado: (2023)

Editorial: New insights into renal fibrosis and therapeutic effects of natural products volume II
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023)

Editorial: Eicosanoids in cancer, Volume II
por: Patrignani, Paola, et al.
Publicado: (2023)

Editorial: Apoptosis Induction/Suppression: A Feasible Approach for Natural Products to Treatment of Diseases, Volume II
por: Peng, Wei, et al.
Publicado: (2022)

Editorial: Venoms, animal and microbial toxins, volume II
por: Cao, Zhijian, et al.
Publicado: (2022)

Editorial: Current Aspects in Chemopreventive Strategies, Volume II
por: Tuli, Hardeep Singh, et al.
Publicado: (2022)

Editorial: Autophagy in inflammation related diseases, volume II
por: Shao, Bo-Zong, et al.
Publicado: (2023)

Editorial: Antimalarial chemotherapy in the XXIst century, volume II
por: Gomes, Paula, et al.
Publicado: (2023)

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2023)

Editorial: The role of medicinal plants and natural products in modulating oxidative stress and inflammatory related disorders, Volume II
por: Agbor, Gabriel A., et al.
Publicado: (2023)

Editorial: The roles of ion-induced cell death in cancer treatment: volume II
por: Zhang, Kui, et al.
Publicado: (2023)

Ganglioside GM1 Targets Astrocytes to Stimulate Cerebral Energy Metabolism
por: Finsterwald, Charles, et al.
Publicado: (2021)

Editorial: Imaging technology in oncology pharmacological research, volume II
por: Zeng, Qi, et al.
Publicado: (2022)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease, Volume II
por: Bucolo, Claudio, et al.
Publicado: (2022)

Editorial: Hydrogen sulfide: Physiology, Pharmacology and Toxicology, Volume II
por: Bian, Jin-Song
Publicado: (2022)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Resolution of inflammation: Mechanisms, mediators and biomarkers: Volume II
por: Patrignani, Paola, et al.
Publicado: (2022)

Editorial: Neurodegeneration, cell signaling and neuroreparative strategies, Volume II
por: Vaz, Ana Rita, et al.
Publicado: (2023)

Editorial: Microbiome in IBD: From Composition to Therapy, Volume II
por: Liu, Ning-Ning, et al.
Publicado: (2023)

Editorial: Experimental models of epilepsy and related comorbidities, Volume II
por: Shaikh, Mohd Farooq, et al.
Publicado: (2023)

Editorial: Medication safety in COVID-19 management, Volume II
por: Das, Saibal
Publicado: (2023)

Editorial: Receptor biology and cell signaling in diabetes: volume II
por: Srivastava, Swayam Prakash, et al.
Publicado: (2023)

Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

Editorial: The biochemistry of amyloids in neurodegenerative diseases, volume II
por: Gomes, Cláudio M., et al.
Publicado: (2023)

Editorial: Therapeutic Index for Nutraceuticals in Inflammation-Related Diseases: Efficacy, Bioavailability, Metabolism and Interactions With Drugs, Volume II
por: Peluso, Ilaria, et al.
Publicado: (2022)

Editorial: Application of plant secondary metabolites to pain neuromodulation, volume II
por: Singla, Rajeev K., et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II
por: Thermos, Kyriaki, et al.
Publicado: (2022)

Editorial: Application of computational tools to health and environmental sciences, Volume II
por: Ruiz, Patricia, et al.
Publicado: (2022)

Editorial: Novel approaches to the treatment of multidrug-resistant bacteria, Volume II
por: Pusparajah, Priyia, et al.
Publicado: (2022)

Editorial: Reducing the harm of medication–recent trends in pharmacovigilance (volume II)
por: Ramírez, Elena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mjtqviprmtoqcao409buv1afsa